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Purpose: Prostate cancer screening with PSA is plagued by high rate of
unnecessary prostate biopsies, especially in the “gray zone” (4.0ng/ml e
10.0ng/ml). We introduce a new circulating-tumor-cell (CTC) biomarker
for detection of prostate cancer in patients in the PSA “gray zone” level,
with the clinically veriﬁed potential to substantially decrease the number
of unnecessary prostate biopsies.
Materials and Methods: A total of 97 patients underwent routine prostate
screening including PSA testing and DRE. One tube of blood was drawn for
each patient and sent for CTC analysis in a double blinded study. A subset
of 23 patients with PSA in the 4.0ng/ml e 10.0ng/ml range was selected
with consent to undergo prostate biopsy for comparison with blinded CTC
test results. The CTC test utilized a microﬂuidic platform with EpCAM as
capture antibody. Suspected CTCs were eluted to a membrane chip and
immunoﬂuorently stained with CK18, PSMA and CD45 antibody to
conﬁrm. Positive CTCs are deﬁned as CK18+ or PSMA+ and CD45-.
Results: Prostate cancer was conﬁrmed by biopsy in 60 out of 97 patients.
CTC assay reported 83% of the cancer cases, demonstrating prostate cancer
detection ability of the assay. In the subset category of 23 patients (PSA in
the 4.0ng/ml e 10.0ng/ml range, and prostate biopsy), the CTC assay was
able to detect cancer in 100% of the prostate cancer cases.
Conclusion: This CTC-based blood test is a valuable new tool in effective
screening for prostate cancer. We have demonstrated that this new CTC
biomarker is able to reduce unnecessary invasive prostate biopsies in the
PSA “gray zone” by over 60%, with the potential to reduce cost to the
system and reduce complication rates due to prostate biopsies, thus
improving patient outcomes.
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Purpose: Urothelial carcinoma (UC) is the most common malignancy
involving urinary bladder (UB) and upper urinary tract (UT) for which the
theranostic markers remain under-investigated. Increasing evidence has
shown that protein tyrosine phosphatases (PTPs) play dominant roles in
setting the levels of tyrosine phosphorylation and promote oncogenic
processes. However, their expression has not been systemically investi-
gated in UC, and our aim is to examine their potential impact on UC.
Materials and Methods: We performed data mining from a published
transcriptome of UBUCs (GSE32894), and PTP type IVA member 3 (PTP4A3)
was identiﬁed as the most signiﬁcantly upregulated gene among those
related to prenylated PTP activity (GO: 0004727). The importance of PTP4A3
was initially analyzed in paired normal urothelium, non-invasive UC, inva-
sive UC, and nodal metastatic tissue. PTP4A3 transcript level was assessed in
snap-frozen UC samples by laser capture microdissection and real-time RT-
PCR. PTP4A3 protein expressionwas determined by immunohistochemistry
in 295 UBUCs and 340 UTUCs, respectively. The association of PTP4A3
expressionwith clinicopathological features, disease-speciﬁc survival (DSS),
and metastasis-free survival (MeFS) was further evaluated.
Results: For both UBUC and UTUC, the level of PTP4A3 signiﬁcantly
increased from normal urothelium, non-invasive UC, invasive UC, to nodal
metastatic tissue (both p< 0.001). The PTP4A3 transcript level was also
markedly upregulated in high stage UC (UBUC, p< 0.001; UTUC,
p¼ 0.002). Overexpression of PTP4A3 protein was signiﬁcantly associated
with advanced pT status, nodal metastasis, and lymphovascular invasion
(all p< 0.001). PTP4A3 overexpression not only predicted worse DSS and
MeFS on univariate analysis (all p< 0.001), but also implicated in inferior
DSS (UBUC, p< 0.001; UTUC, p¼ 0.001) andMeFS (UBUC, p¼ 0.003; UTUC,
p¼ 0.001) on multivariate analysis.
Conclusion: PTP4A3 overexpression independently predicted metastasis
and outcome of both UBUC and UTUC, suggesting its potential theranostic
value in UC.
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Purpose: Inﬂammation-related parameters based on blood cells, including
white blood cell (WBC) count, neutrophil-lymphocyte ratio, platelet count,
and red cell distributionwidth (RDW),have been shown to be associatedwith
prognosis in many cancers. We aimed to evaluate these inﬂammation-asso-
ciated markers simultaneously in upper tract urothelial carcinoma (UTUC).
Materials and Methods: A total of 195 patients with UTUC who received
radical nephroureterectomy between 2005 and 2010 were included
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inﬂammation markers on overall survival (OS) and cancer-speciﬁc survival
(CSS). In turn, another independent set of 225 patients were used for
validation. Finally, we performed survival analysis in the combined cohort
consisting of 420 UTUC patients.
Results: The predictive value of RDW and WBC count on outcome was
replicable in different cohorts. Multivariate analysis showed high RDWwas
independently associated with poor OS (P< 0.001), and WBC count was a
signiﬁcant prognosticator for both OS and CSS (both P< 0.001). In subgroup
analysis, we found the prognostic signiﬁcance of RDW for OS was limited in
organ-conﬁned disease (pT2 without pN+). More importantly, a clear
survival difference can be demonstrated by combining RDWandWBC count
with other known prognostic factors in the risk stratiﬁcation model.
Conclusion: RDW and WBC count have the advantage of their common
accessibility and are useful markers to predict outcome of UTUC in the
preoperative setting. RDW and WBC count could provide additional
prognostic value and help physicians identify patients at high risk for
mortality and formulate individualized treatment strategy.
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Background: Human bladder cancer (BC) cells exhibited a high basal level
of autophagic activity demonstrated by accumulating of acridine orange
(AO)-stained acidic vesicular organelles (AVOs) in BC cells. In this study, we
aim to investigate the cytotoxicity effects of AO on the human BC cell lines
under blue-light exposure.
Materials and Methods: To evaluate phtotoxicities of AO toward human
bladder cancer cells, we designed and developed a blue-light source
equipped with 6 blue-light LED (peak wavelength: 443.7 nm). The AO
relocalization in treated-BC cells was recorded using a ﬂuorescence mi-
croscopy equipped with a color CCD camerain a real-time fashion. The cell
viability was determined using (a) WST-1 reagents (immediately after
treatment for 1 hour), (b) continuous quantiﬁcation with Cytation 5 Cell
ImagingMulti-mode reader (Biotek Instruments, Inc., for 24 hours), and (c)
time-lapse imaging with a cell imaging recorder (Cytosmart System,
Lonza; for 36 hours) in human immortalized uroepithelial (SV-Huc1) and
BC cell lines (5637 and T24) treated with indicated concentration of AO
with or without blue light exposure.
Results: The AO relocationwas clearlymonitored by ﬂuorescentmicroscopy
with decreased red ﬂuorescent intensity over exposure duration within 5-
15 secounds in BC cells. Treatment ofAO or blue-light exposure alone did not
cause a signiﬁcant decrease of cell viability in BC cells. However, we found
that AO exhibited a dose-dependent increment of cytotoxicity toward BC
cells with blue-light exposure (AO-PDT). In addition, this phenomenon was
more prominent in human BC cell lines compared to SV-Huc1 cells. These
results suggested that AO, as a photosensitizer, disrupts acidic organelles in
BC cells under blue light irradiation in BC cells.
Conclusion: Blue light irradiation in BC cell treated with AO causes severe
cell death. The photodynamic effect can be applied clinically to an existing
instrument, namely narrow band image endoscopic system, to deliver blue
light. The AO-PDT may serve as a novel therapeutic strategy to reduce
recurrence or against human bladder cancer in the future.
PD1-5:
THE URINARY MICROPARTICLE TUMOR-ASSOCIATED CALCIUM-SIGNAL
TRANSDUCER 2 AS A BLADDER CANCER BIOMARKER
Chien-LunChen1,2, PetrusTang 1,2, Chih-ChingWu1,2, TingChung1,2, Jau-Song
Yu1,2, Yu-Sun Chang 1,2, Phei-Lang Chang1,2, Yi-Ting Chen 1,2. 1Department of
Urology, Chang Gung Memorial Hospital, Linko, Taiwan; 2Chang Gung
University, Taoyuan, TaiwanPurpose: In contrast to PSA for prostate cancer, no reliable bladder cancer
biomarker is currently widely applicable for the detection and follow-up of
bladder cancer. We employed a strategy combining isotopic dimethylation
labeling coupled with liquid chromatography-tandem mass spectrometry
(LCMS/MS) to discover bladder cancer biomarkers in urinary micropar-
ticles isolated from hernia (control) and bladder cancer patients.
Materials and Methods: The urine specimens of bladder cancer patients
and age-matched hernia patients (n¼ 81) were collected in the morning of
surgery. The surgically resected bladder tumors were all pathologically
identiﬁed and determined into 3 groups for comparison; namely, Low-
grade/Early stage (LgEs, n¼ 40), High-grade/Early stage (HgEs, n¼ 63), and
High-grade/ Advanced-stage (HgAs, n¼ 37).
Results: A total of 107 proteins out of 2964 proteins were identiﬁed in this
approach as candidate biomarkers. Differences in the concentrations of 29
proteins were precisely quantiﬁed by LCMRM/MS. There were 24 pro-
teins changed signiﬁcantly (p< 0.05) between bladder cancer and hernia.
TACSTD2 concentrations measured by LC-MRM/MSwere 6.5-fold higher in
bladder cancer urinary microparticles than in hernia urinary microparti-
cles. In raw urine specimens (n¼ 221) using ELISA, the area-under-the-
curve values of TACSTD2 was 0.80.
Conclusion: Our study revealed that TACSTD2 showed strong association
with bladder canLcer in urine specimens, and thus represents a potential
biomarker for noninvasive screening for bladder cancer.
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Purpose: Cancer stem cells were considered to be the genesis of cancer
and account for cancer initiation, progression, and recurrence. Studies
have highlighted a role for Hexokinase 2 (HK2) in facilitating tumor growth
and lactate production, which is downstream product of HK2 reaction in
cancer cells. Tumor cells can extrude and shuttle lactate to neighboring
cancer cells, adjacent stromal cells, and vascular endothelial cells to induce
signaling molecular change. However, in tumor microenvironment, the
molecular mechanisms underlying this association of tumor lactate shut-
tle, HK2 activity and cancer metastases were not well established. In this
study, we explored the role of lactate shuttle induced by HK2 in cancer
stem cell formation and epithelial-mesenchymal transition (EMT) be-
tween bladder cancer cells in vitro and in vivo.
Materials and Methods: The endogenous HK2 in human bladder cancer
(TCCSUP, J82 and TSGH8301) and normal (SVHUC) cells was examined by
immunoblot and immunoﬂuoscence. Effects of lactate exposure on cell
proliferation, morphologic change and cancer stem cell phenotype were
analyzed in human bladder cancer cells. Stable HK2-overexpression and
eknockdown clones were also examined for their effects on EMT, lactate
secretion, NF-kB phosphorylation and CD133 activity in vitro and mouse
models. The animal survival and lung metastasis were assessed in a mouse
subcutaneous model using TSGH8301 cells with HK2-overexpression
clones. All statistical tests were two-sided.
Results: The HK2 expression was signiﬁcantly higher in bladder cancers
compared with normal cells. The urine lactate detection was higher in
human bladder cancers than in non-cancer subjects (204.9 vs 54.79 mM;
P< 0.001). Stable HK2 overexpression induced cell proliferation, and
showed morphologic changes with gain of cancer stem cell markers. HK2
knockdown also reduced lactate extrusion in vitro. In response to lactate
exposure, nuclear translocation of NF-kB phosphorylation and Twist1 as
well as mesenchymal markers was promoted in human bladder cancer
cells. In addition, lactate exposure enhanced CD133 activity in vitro. Inmice
bearing subcutaneous tumors, increased tumor growth and lung metas-
tasis were observed in stable HK2-overexpression cancers compared with
mock counterparts (survival, P¼ 0.034). In animal models, HK2-over-
expression cancers also induced morphologic change and CD133 activity.
